MSD-SP LTD

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
E-mail: medicalinformation@merck.com
Medical Information Fax: +44 (0)1992 479 292

Patient Information Leaflet last updated on the eMC: 23/01/2012
PIL INEGY Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 28/07/2011 and displayed until 23/01/2012
Reasons for adding or updating:
  • Change of contra-indications
  • Change to drug interactions
  • Change to warnings or special precautions for use
Updated on 22/03/2011 and displayed until 28/07/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 27/10/2010 and displayed until 22/03/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to dosage and administration
Updated on 17/02/2010 and displayed until 27/10/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 23/09/2009 and displayed until 17/02/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 01/07/2008 and displayed until 23/09/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/05/2008 and displayed until 01/07/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 31/07/2007 and displayed until 16/05/2008
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 14/11/2006 and displayed until 31/07/2007
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
Updated on 27/01/2006 and displayed until 14/11/2006
Reasons for adding or updating:
  • No reasons supplied
Updated on 27/07/2005 and displayed until 27/01/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change of manufacturer
  • Change to drug interactions
Updated on 03/06/2005 and displayed until 27/07/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   simvastatin
   ezetimibe